Skip to content

Author

Emily Paul

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Abstract IA003: Targeting the antigenic landscape that emerges after KRAS inhibition for PDAC immunotherapy

Targeting the antigenic landscape that emerges after KRAS inhibition for PDAC immunotherapy holds significant translational potential as KRAS inhibitors are poised to become a mainstay in PDAC treatment and treatment induced antigens may serve as the foundation for rationally designed combination immunotherapies.

Alex M. Jaeger, Emma Adhikary, Andrew Deonarine et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.